biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Corporate Presentation - DrDR Is AWOL!!

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Jan 25, 2023 12:01pm

134 Views

Post# 35245372

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Corporate Presentation - DrDR Is AWOL!!

Point taken, zwerp2000, but ridicule and abject defeatism seem to be your incessant message. You might call your ridicule sarcasm but readers will call it what they want.

At 3¢ and no money, we understand the situation and the feeling of defeat, but it's hardly helpful to dwell on defeat.

Other than the company's own behaviour, this forum has by far the largest influence on shareholder opinions. There just isn't any other place to go with this penetration and influence.

jd

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing